[fcb5af]: / literature / by_gene / PRKCB.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35411950 10.1002/cbf.3702 2022 USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. PRKCB
2 32779615 10.3960/jslrt.20019 2021 Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. PRKCB
3 33098696 10.1111/ejh.13540 2021 RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma. PRKCB
4 33241658 10.1111/jcmm.16117 2021 Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin. PRKCB
5 33426772 10.1111/cas.14806 2021 Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. PRKCB
6 31757376 10.1016/j.jtho.2019.07.021 2020 Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib. PRKCB
7 31883669 10.1016/j.pathol.2019.09.014 2020 The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. PRKCB
8 31961925 10.1182/blood.2019001815 2020 Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. PRKCB
9 29084771 10.1182/blood-2017-01-761874 2019 Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. PRKCB
10 30097855 10.1007/s10689-018-0099-x 2019 Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma. PRKCB
11 31035338 10.3390/ijms20092089 2019 Marek's Disease Virus Regulates the Ubiquitylome of Chicken CD4<sup>+</sup> T Cells to Promote Tumorigenesis. PRKCB
12 27835906 10.18632/oncotarget.13239 2018 Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma. PRKCB
13 28246354 10.1042/BSR20160445 2018 Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin. PRKCB
14 28115366 10.1182/blood-2016-09-692574 2017 Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. PRKCB
15 28369050 10.1038/ni.3716 2017 Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. PRKCB
16 28627735 10.1111/cas.13303 2017 Genetic alterations in adult T-cell leukemia/lymphoma. PRKCB
17 28694326 10.1182/blood-2017-02-768234 2017 Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). PRKCB
18 25693686 10.1093/abbs/gmv003 2016 Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2. PRKCB
19 26437031 10.1038/ng.3415 2016 Integrated molecular analysis of adult T cell leukemia/lymphoma. PRKCB
20 26462016 10.18632/oncotarget.5462 2016 Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo. PRKCB
21 27169444 10.11406/rinketsu.57.417 2016 [Genetic landscape of adult T-cell leukemia/lymphoma]. PRKCB
22 25502755 10.1038/ncomms6719 2015 An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. PRKCB
23 25548371 10.1093/jmcb/mju050 2015 Protein kinase C-δ and -β coordinate flow-induced directionality and deformation of migratory human blood T-lymphocytes. PRKCB
24 26121314 10.1038/labinvest.2015.83 2015 Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing. PRKCB
25 21997316 10.2310/JIM.0b013e318237eb55 2013 Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells. PRKCB
26 23328482 10.1016/j.ccr.2012.12.003 2013 Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. PRKCB
27 23861246 10.1182/blood-2013-01-478156 2013 Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. PRKCB
28 20439192 10.3816/CLC.2010.n.021 2010 Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer. PRKCB
29 20846475 2010 Specific inhibition of protein kinase Cbeta expression by antisense RNA affects the activation of Jurkat T lymphoma cells. PRKCB
30 17926183 10.1080/10428190701636443 2008 Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. PRKCB
31 15090600 10.1242/jcs.00955 2005 Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. PRKCB
32 14699138 10.1074/jbc.M306672200 2004 Ki-1/57 interacts with RACK1 and is a substrate for the phosphorylation by phorbol 12-myristate 13-acetate-activated protein kinase C. PRKCB
33 12730099 10.1182/blood-2002-11-3621 2003 Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3. PRKCB
34 12118249 10.1038/ni823 2002 PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. PRKCB
35 10641798 10.1016/s1357-2725(99)00097-7 2000 HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system. PRKCB
36 10212259 10.1074/jbc.274.18.12753 1999 Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation. PRKCB